Natural killer cells expanded in vivo or ex vivo with IL-15 overcomes the inherent susceptibility of CAST mice to lethal infection with orthopoxviruses.

by Patricia L Earl, Jeffrey L Americo, Bernard Moss
Published 2020-04-01

Novel Nonreplicating Vaccinia Virus Vector Enhances Expression of Heterologous Genes and Suppresses Synthesis of Endogenous Viral Proteins

by Linda S. Wyatt, Wei Xiao, Jeffrey L. Americo, Patricia L. Earl, Bernard Moss, Terence S. Dermody
Published 2017-06-01

HIV-DNA Given with or without Intradermal Electroporation Is Safe and Highly Immunogenic in Healthy Swedish HIV-1 DNA/MVA Vaccinees: A Phase I Randomized Trial.

by Charlotta Nilsson, Bo Hejdeman, Karina Godoy-Ramirez, Teghesti Tecleab, Gabriella Scarlatti, Andreas Bråve, Patricia L Earl, Richard R Stout, Merlin L Robb, Robin J Shattock, Gunnel Biberfeld, Eric Sandström, Britta Wahren
Published 2015-01-01

Heterologous prime-boost regimens using rAd35 and rMVA vectors elicit stronger cellular immune responses to HIV proteins than homologous regimens.

by Silvia Ratto-Kim, Jeffrey R Currier, Josephine H Cox, Jean-Louis Excler, Anais Valencia-Micolta, Doris Thelian, Vicky Lo, Eddy Sayeed, Victoria R Polonis, Patricia L Earl, Bernard Moss, Merlin L Robb, Nelson L Michael, Jerome H Kim, Mary A Marovich
Published 2012-01-01